Gregory T. Lucier
Gregory T. Lucier (born 9 May 1964) is the Chairman and former CEO of NuVasive, Inc.[1] He was previously CEO of DNA-sequencing company Life Technologies.[2]
Education[edit]
Lucier received his B.S. in Engineering at Pennsylvania State University, and earned his MBA from Harvard Business School.[3][4]
Career[edit]
Gregory T. Lucier has been the Chairman and CEO of NuVasive, Inc. since 2014, and serves as Chairman of the Board at Epic Sciences and Catalent Corporation (CTLT).[1][3]
Earlier in his career, he was a corporate officer at General Electric. He was president of medical information technology at GE Healthcare, and was promoted to vice president of global services, the company's $2 billion healthcare services business.[3]
In 2003, he left GE to join life sciences company Invitrogen.[5] In 2008, Life Technologies was formed by the 2008 merger of Invitrogen and Applied Biosystems.[5] Lucier became CEO and Chairman of the combined company. In 2011, he was #12 on Forbe's list of highest paid CEOs.[6] He remained with the company until 2014, after selling the company to Thermo Fisher Scientific for $13.6 billion in 2013.[7][8] In 2013, he had joined NuVasive's Board of Directors, and became the company's CEO in 2014.[9][1]
Lucier has served on the Board of Directors at Invuity (now Stryker), CareFusion Corporation (now Becton Dickinson), Synthetic Genomics, Rady Children's Hospital, California Healthcare Institute and BIOCOM Inc.[10]
References[edit]
- ↑ 1.0 1.1 1.2 "NuVasive CEO Greg Lucier steps down; Medtronic executive takes over at spinal surgery products firm". sandiegouniontribune.com. 2018-10-22. Retrieved 2018-11-13.
- ↑ "Is There Life after Life Tech for Greg Lucier?". genengnews.com. 2014-02-26. Retrieved 2018-11-13.
- ↑ 3.0 3.1 3.2 Garrity, Mackenzie. "5 things to know about NuVasive CEO Greg Lucier". Retrieved 2018-10-24.
- ↑ "Penn State College of Engineering". engr.psu.edu. Retrieved 2018-11-14.
- ↑ 5.0 5.1 "Thermo Fisher divests to speed Life Tech deal". sandiegouniontribune.com. 2014-01-06. Retrieved 2018-11-13.
- ↑ "CEO Compensation - #12 Gregory T Lucier". forbes.com. Retrieved 2018-11-14.
- ↑ "Life Tech to be sold for $13.6 billion". sandiegouniontribune.com. 2013-04-15. Retrieved 2018-11-13.
- ↑ "Lucier named CEO at NuVasive". modernhealthcare.com. 2015-05-26. Retrieved 2018-11-13.
- ↑ "Gregory T Lucier to join NuVasive's board of directors". spinalnewsinternational.com. 2013-12-04. Retrieved 2018-11-14.
- ↑ "Greg Lucier Overview".
This article "Gregory T. Lucier" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Gregory T. Lucier. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
